Literature DB >> 33754695

Hybrid Tellurium-Lignin Nanoparticles with Enhanced Antibacterial Properties.

A Gala Morena1, Arnau Bassegoda1, Javier Hoyo1, Tzanko Tzanov1.   

Abstract

The surge of antibiotic-resistant bacteria is leading to the loss of effectiveness of antibiotic treatment, resulting in prolonged infections and even death. Against this healthcare threat, antimicrobial nanoparticles that hamper the evolution of resistance mechanisms are promising alternatives to antibiotics. Herein, we used Kraft lignin, a poorly valorized polymer derived from plant biomass, to develop novel hybrid tellurium-lignin nanoparticles (TeLigNPs) as alternative antimicrobial agents. The sonochemically synthesized TeLigNPs are comprised of a lignin matrix with embedded Te clusters, revealing the role of lignin as both a reducing agent and a structural component. The hybrid NPs showed strong bactericidal effects against the Gram-negative Escherichia coli and Pseudomonas aeruginosa, achieving more than 5 log bacteria reduction, while they only slightly inhibited the growth of the Gram-positive Staphylococcus aureus. Exposure of TeLigNPs to human cells did not cause morphological changes or reduction in cell viability. Studies on the antimicrobial mechanism of action demonstrated that the novel TeLigNPs were able to disturb bacterial model membranes and generate reactive oxygen species (ROS) in Gram-negative bacteria.

Entities:  

Keywords:  antibacterial activity; green synthesis; hybrid nanoparticles; lignin; sonochemistry; tellurium

Year:  2021        PMID: 33754695     DOI: 10.1021/acsami.0c22301

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  1 in total

1.  Antibacterial Properties and Mechanisms of Action of Sonoenzymatically Synthesized Lignin-Based Nanoparticles.

Authors:  Angela Gala Morena; Arnau Bassegoda; Michal Natan; Gila Jacobi; Ehud Banin; Tzanko Tzanov
Journal:  ACS Appl Mater Interfaces       Date:  2022-08-12       Impact factor: 10.383

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.